Brii Biosciences Limited
BRIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$512,381 | -$184,370 | -$489,781 | -$4,191,084 |
| Dep. & Amort. | $8,850 | $15,674 | $17,032 | $17,262 |
| Deferred Tax | $0 | $0 | $0 | -$44,795 |
| Stock-Based Comp. | $16,051 | $64,223 | $77,928 | $79,370 |
| Change in WC | -$50,409 | -$120,733 | -$76,994 | -$333,742 |
| Other Non-Cash | $164,999 | -$368,808 | -$24,464 | $3,593,532 |
| Operating Cash Flow | -$372,890 | -$594,014 | -$496,279 | -$879,457 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,228 | $0 | -$139,292 | -$1,029 |
| Net Acquisitions | $0 | $0 | $0 | $1,623 |
| Inv. Purchases | -$1,943,360 | -$3,487,006 | -$2,101,905 | -$499,647 |
| Inv. Sales/Matur. | $2,848,092 | $3,268,132 | $774,813 | $20,107 |
| Other Inv. Act. | -$6,034 | $114,524 | $33,216 | $3,190 |
| Investing Cash Flow | $895,470 | -$104,350 | -$1,433,168 | -$475,756 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6,873 | -$9,500 | -$8,960 | -$9,745 |
| Stock Issued | $53 | $179 | $7,447 | $2,325,229 |
| Stock Repurch. | -$220 | -$1,162 | -$678 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,366 | -$494 | -$851 | $914,650 |
| Financing Cash Flow | -$9,406 | -$10,977 | -$3,042 | $3,230,134 |
| Forex Effect | $541 | $8,419 | $267,968 | -$54,793 |
| Net Chg. in Cash | $513,715 | -$700,922 | -$1,664,521 | $1,820,128 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $489,650 | $1,190,572 | $2,855,093 | $1,034,965 |
| End Cash | $1,003,365 | $489,650 | $1,190,572 | $2,855,093 |
| Free Cash Flow | -$376,118 | -$643,622 | -$635,571 | -$880,486 |